Insights

Emerging Biotech Scale MicroProtein Technologies is a small biotech player with revenue in the low single digits to mid single digits and an R&D oriented profile, signaling growth potential for contract manufacturing, custom protein production platforms, and early-stage collaborations with larger pharma/biotech partners.

Innovative Platform The patented MPTxpress technology and recent 8K context window capability suggest opportunities to offer advanced computational biology services, AI-assisted protein design, and scalable production workflows to diagnostics, biopharma, and veterinary markets.

Global Tech Stack Adoption of enterprise tools like iCIMS, Google Workspace, and e-commerce/payments platforms indicates readiness for formal sales processes, partner onboarding, and potential integration services for data management, collaboration, and customer experience improvements.

Strategic Partnerships The company operates in a high-visibility field with peers at large global players; there are clear opportunities to pursue co-development deals, licensing of MPTxpress capabilities, or supplier relationships to expand service offerings and reach.

Market Positioning With a focus spanning biotechnology research to pre-clinical and clinical applications, there is a pathway to target mid-to-large biotech and diagnostic firms seeking innovative recombinant biologics solutions, enabling cross-sell of platform services, custom proteins, and analytics.

MicroProtein Technologies, Inc. Tech Stack

MicroProtein Technologies, Inc. uses 8 technology products and services including iCIMS, WordPress, WooCommerce, and more. Explore MicroProtein Technologies, Inc.'s tech stack below.

iCIMS

Applicant Tracking Systems

WordPress

Content Management System

WooCommerce

E-commerce

Google Workspace

Underscore.js

Javascript Libraries

Really Simple Discovery

Miscellaneous

PayPal

Payment Processing

Piwik PRO Core

Web Analytics

MicroProtein Technologies, Inc. Email Formats	Example	Percentage
First@mptbiotechs.com	John@mptbiotechs.com	100%

MicroProtein Technologies, Inc. Email Formats

Example

Percentage

First@mptbiotechs.com

John@mptbiotechs.com

100%

Frequently Asked Questions

What is MicroProtein Technologies, Inc.'s phone number?

You can contact MicroProtein Technologies, Inc.'s main corporate office by phone at

+1-913-851-****

. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is MicroProtein Technologies, Inc.'s official website and social media links?

MicroProtein Technologies, Inc.'s official website is mptbiotechs.com and has social profiles on LinkedIn.

How much revenue does MicroProtein Technologies, Inc. generate?

As of September 2026, MicroProtein Technologies, Inc.'s annual revenue is estimated to be $1M - $10M.

What is MicroProtein Technologies, Inc.'s SIC code and NAICS code?

MicroProtein Technologies, Inc.'s SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does MicroProtein Technologies, Inc. have currently?

As of September 2026, MicroProtein Technologies, Inc. has approximately 3 employees across 1 continents, including North America. Key team members include Senior Vice President-Business Development And Strategy: S. R. Explore MicroProtein Technologies, Inc.'s employee directory with LeadIQ.

What industry does MicroProtein Technologies, Inc. belong to?

MicroProtein Technologies, Inc. operates in the Biotechnology Research industry.

What technology does MicroProtein Technologies, Inc. use?

MicroProtein Technologies, Inc.'s tech stack includes iCIMS, WordPress, WooCommerce, Google Workspace, Underscore.js, Really Simple Discovery, PayPal and Piwik PRO Core.

What is MicroProtein Technologies, Inc.'s email format?

MicroProtein Technologies, Inc.'s email format typically follows the pattern of First@mptbiotechs.com. Find more MicroProtein Technologies, Inc. email formats with LeadIQ.

When was MicroProtein Technologies, Inc. founded?

MicroProtein Technologies, Inc. was founded in 2008.

MicroProtein Technologies, Inc.

Q: What technology does MicroProtein Technologies, Inc. use?

MicroProtein Technologies, Inc.'s tech stack includes WordPress, Elementor, LiteSpeed Cache, Sitelinks Search Box, Piwik PRO Core.

Q: What is MicroProtein Technologies, Inc.'s NAICS code?

MicroProtein Technologies, Inc.'s NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).

Biotechnology ResearchKansas, United States2-10 Employees

MicroProtein Technologies, Inc. is a biotechnology research company based in Overland Park, Kansas. It describes itself as a pioneer in its field and focuses on developing recombinant biologics, including proteins, enzymes, peptides, and AI-designed proteins, with applications across biotechnology, diagnostics, biopharmaceuticals, veterinary medicine, and pre-clinical to clinical development. The firm positions its technology as enabling production of these biologics, aiming to support longer-term research and development efforts in diverse life-science domains. The company’s location and small size suggest a specialized, early-stage operation concentrated on advanced protein science. In June 2023, MicroProtein Technologies announced the launch of an 8K context window for its MPT-30B, a development noted in media coverage. } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } }

Insights

Similar companies to MicroProtein Technologies, Inc.

Bio-Rad Laboratories

Danaher

Sartorius

Bruker

Waters Corporation

Thermo Fisher Scientific

Agilent Technologies

PerkinElmer

SCIEX